Drug industry to announce revised code on marketing
Gifts that drug makers have long showered on doctors will be banned from pharmaceutical marketing campaigns under new voluntary guidelines titled the "Code on Interactions with Health Care Professionals." The guidelines will ask the chief executives of large drug makers to certify in writing that "they have policies and procedures in place to foster compliance with the code." The code, however, provides no definite limits on the millions of dollars spent on speaking and consulting arrangements that drug makers have forged with doctors. The code was written by the Pharmaceutical Research and Manufacturers of America.
- Governors Push to Expand Role of PAs, Telemedicine
- 3 More Pioneer ACOs Say They Will Quit
- Why Open Payments Irks Physicians
- Telemetry Overuse Cost Health System $4.8 Million in One Year
- Ebola in the U.S.: Reason to Fear, to Hope, to Prepare
- Top Provider Billing Mistakes Are Changing
- Overcoming a Payer Mix 'Nightmare'
- Employee Engagement: Make It Meaningful
- Difficult Patients: It's Not Them, It's You, Doctor
- IV Fluids Shortage Continues